Heteroaromatic analogues of the alpha 2-adrenoreceptor partial agonist clonidine. 1989

C B Chapleo, and R C Butler, and D C England, and P L Myers, and A G Roach, and C F Smith, and M R Stillings, and I F Tulloch
Department of Pharmacology, Reckitt & Colman plc, Pharmaceutical Division, Kingston-upon-Hull, U.K.

A 1,4-dioxane analogue (1) of the alpha 2-adrenoreceptor partial agonist clonidine (2) has previously been shown to possess an interesting but complex pharmacological profile. In this study, from a series of other heterocyclic analogues of clonidine, the 1,4-oxazines 6 and 12 were found to resemble 1 in that they are partial alpha 2-agonists in the periphery and are excluded from the central nervous system. However, when given directly into the brain, they behave as pure alpha 2-antagonists.

UI MeSH Term Description Entries
D008297 Male Males
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D003000 Clonidine An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION. Catapres,Catapresan,Catapressan,Chlophazolin,Clofelin,Clofenil,Clonidine Dihydrochloride,Clonidine Hydrochloride,Clonidine Monohydrobromide,Clonidine Monohydrochloride,Clopheline,Dixarit,Gemiton,Hemiton,Isoglaucon,Klofelin,Klofenil,M-5041T,ST-155,Dihydrochloride, Clonidine,Hydrochloride, Clonidine,M 5041T,M5041T,Monohydrobromide, Clonidine,Monohydrochloride, Clonidine,ST 155,ST155
D006571 Heterocyclic Compounds Cyclic compounds that include atoms other than carbon in their ring structure. Heterocyclic Compound,Compound, Heterocyclic,Compounds, Heterocyclic
D000316 Adrenergic alpha-Agonists Drugs that selectively bind to and activate alpha adrenergic receptors. Adrenergic alpha-Receptor Agonists,alpha-Adrenergic Receptor Agonists,Adrenergic alpha-Agonist,Adrenergic alpha-Receptor Agonist,Receptor Agonists, Adrenergic alpha,Receptor Agonists, alpha-Adrenergic,alpha-Adrenergic Agonist,alpha-Adrenergic Agonists,alpha-Adrenergic Receptor Agonist,Adrenergic alpha Agonist,Adrenergic alpha Agonists,Adrenergic alpha Receptor Agonist,Adrenergic alpha Receptor Agonists,Agonist, Adrenergic alpha-Receptor,Agonist, alpha-Adrenergic,Agonist, alpha-Adrenergic Receptor,Agonists, Adrenergic alpha-Receptor,Agonists, alpha-Adrenergic,Agonists, alpha-Adrenergic Receptor,Receptor Agonist, alpha-Adrenergic,Receptor Agonists, alpha Adrenergic,alpha Adrenergic Agonist,alpha Adrenergic Agonists,alpha Adrenergic Receptor Agonist,alpha Adrenergic Receptor Agonists,alpha-Agonist, Adrenergic,alpha-Agonists, Adrenergic,alpha-Receptor Agonist, Adrenergic,alpha-Receptor Agonists, Adrenergic
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014649 Vas Deferens The excretory duct of the testes that carries SPERMATOZOA. It rises from the SCROTUM and joins the SEMINAL VESICLES to form the ejaculatory duct. Ductus Deferens,Deferens, Ductus,Deferens, Vas
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

C B Chapleo, and R C Butler, and D C England, and P L Myers, and A G Roach, and C F Smith, and M R Stillings, and I F Tulloch
August 1996, Brain research,
C B Chapleo, and R C Butler, and D C England, and P L Myers, and A G Roach, and C F Smith, and M R Stillings, and I F Tulloch
January 2002, Zhurnal vysshei nervnoi deiatelnosti imeni I P Pavlova,
C B Chapleo, and R C Butler, and D C England, and P L Myers, and A G Roach, and C F Smith, and M R Stillings, and I F Tulloch
May 1992, Zentralblatt fur Veterinarmedizin. Reihe A,
C B Chapleo, and R C Butler, and D C England, and P L Myers, and A G Roach, and C F Smith, and M R Stillings, and I F Tulloch
October 1978, Naunyn-Schmiedeberg's archives of pharmacology,
C B Chapleo, and R C Butler, and D C England, and P L Myers, and A G Roach, and C F Smith, and M R Stillings, and I F Tulloch
July 1982, British journal of clinical pharmacology,
C B Chapleo, and R C Butler, and D C England, and P L Myers, and A G Roach, and C F Smith, and M R Stillings, and I F Tulloch
October 1989, Alimentary pharmacology & therapeutics,
C B Chapleo, and R C Butler, and D C England, and P L Myers, and A G Roach, and C F Smith, and M R Stillings, and I F Tulloch
January 2005, Neuroscience and behavioral physiology,
C B Chapleo, and R C Butler, and D C England, and P L Myers, and A G Roach, and C F Smith, and M R Stillings, and I F Tulloch
January 1986, Acta psychiatrica Scandinavica. Supplementum,
C B Chapleo, and R C Butler, and D C England, and P L Myers, and A G Roach, and C F Smith, and M R Stillings, and I F Tulloch
June 1974, Archives internationales de pharmacodynamie et de therapie,
Copied contents to your clipboard!